SCHEMBL8664722

SCHEMBL8664722

O=c1[nH]c(=O)c2sc(Cl)nc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 1/20 0.61
TYRO3 Q06418 2/20 0.36
DYRK1B Q9Y463 2/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
NTRK1 P04629 1/20 0.36
PDGFRA P16234 1/20 0.36
PRKACA P17612 1/20 0.36
LTK P29376 1/20 0.36
GRK5 P34947 1/20 0.36
MAPK8 P45983 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CDK8 P49336 1/20 0.36
CLK2 P49760 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
PRKX P51817 1/20 0.36
NEK2 P51955 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1194456 0.76 RPS6KA3 (0.61) RPS6KA3ROCK1KDM4EALDH1A1RAB9A
SCHEMBL3755970 0.76 RPS6KA3 (1.00) RPS6KA3KDM4EALDH1A1RAB9ABLM
SCHEMBL4570271 0.65 PNP (0.47) RPS6KA3TYRO3DYRK1BAURKADAPK3
SCHEMBL2837685 0.63 MAPT (0.53) RPS6KA3TYRO3DYRK1BKDM4EALDH1A1
SCHEMBL1192740 0.61 CNOT7 (0.49) RPS6KA3TYRO3DYRK1BAURKADAPK3
SCHEMBL338384 0.60 RPS6KA3 (0.52) RPS6KA3DYRK1AKDM4EALDH1A1PMP22
SCHEMBL31214551 0.60 MAPT (0.62) RPS6KA3KDM4EALDH1A1RAB9ABLM
SCHEMBL1218582 0.59 GRIN2D (0.49) TYRO3DYRK1BDYRK1AKDM4EALDH1A1
SCHEMBL30980985 0.59 GRIN2D (0.49) TYRO3DYRK1BDYRK1AKDM4EALDH1A1
SCHEMBL842227 0.59 RPS6KA3 (0.70) RPS6KA3KDM4EALDH1A1BLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636372-B1 Antiviral, antitumor, antimetastatic, immune system enhancing 7-thia-guanosine derivatives ICN PHARMACEUTICALS (US) 1998-12-02 EP disclosed
EP-0348446-B1 ANTIVIRAL ANTITUMOR ANTIMETASTATIC IMMUNE SYSTEM ENHANCING NUCLEOSIDES AND NUCLEOTIDES UNIV BRIGHAM YOUNG (US) 1995-08-09 EP disclosed
EP-0636372-A1 Antiviral, antitumor, antimetastatic, immune system enhancing 7-thia-guanosine derivatives BRIGHAM YOUNG UNIVERSITY (US) 1995-02-01 EP disclosed
EP-0348446-A4 ANTIVIRAL ANTITUMOR ANTIMETASTATIC IMMUNE SYSTEM ENHANCING NUCLEOSIDES AND NUCLEOTIDES 1991-09-25 EP disclosed
US-5041426-A Viricides, antitumor agents BRIGHAM YOUNG UNIVERSITY (US) 1991-08-20 US disclosed
EP-0348446-A1 ANTIVIRAL ANTITUMOR ANTIMETASTATIC IMMUNE SYSTEM ENHANCING NUCLEOSIDES AND NUCLEOTIDES. UNIV BRIGHAM YOUNG (US) 1990-01-03 EP disclosed
US-4880784-A ANTITUMOR AGENTS BRIGHAM YOUNG UNIVERSITY (US) 1989-11-14 US disclosed
WO-1989005649-A1 ANTIVIRAL ANTITUMOR ANTIMETASTATIC IMMUNE SYSTEM ENHANCING NUCLEOSIDES AND NUCLEOTIDES BRIGHAM YOUNG UNIVERSITY (US) 1989-06-29 WO disclosed